• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Authors' Response to "Letter to the Editor" Submitted by S. Wang and W. Liu (re: "Retrospective Study to Examine Prognostic Value of C-Reactive Protein in Patients With Surgically Resectable Non-Small-Cell Lung Cancer".

作者信息

Azzoli Christopher, Huynh Lynn, Yi Denise, Duh Mei S, Cai Beilei

机构信息

Lifespan Cancer Institute, Rhode Island Hospital, Providence, RI.

Analysis Group Inc., Boston, MA.

出版信息

Clin Lung Cancer. 2023 Sep;24(6):e197. doi: 10.1016/j.cllc.2023.04.006. Epub 2023 Apr 25.

DOI:10.1016/j.cllc.2023.04.006
PMID:37198059
Abstract
摘要

相似文献

1
Authors' Response to "Letter to the Editor" Submitted by S. Wang and W. Liu (re: "Retrospective Study to Examine Prognostic Value of C-Reactive Protein in Patients With Surgically Resectable Non-Small-Cell Lung Cancer".
Clin Lung Cancer. 2023 Sep;24(6):e197. doi: 10.1016/j.cllc.2023.04.006. Epub 2023 Apr 25.
2
Comments on "Retrospective Study to Examine Prognostic Value of C-Reactive Protein in Patients With Surgically Resectable Non-Small Cell Lung Cancer".关于《回顾性研究：探讨C反应蛋白在可手术切除的非小细胞肺癌患者中的预后价值》的评论
Clin Lung Cancer. 2023 Sep;24(6):e195-e196. doi: 10.1016/j.cllc.2023.04.005. Epub 2023 Apr 23.
3
Retrospective Study to Examine Prognostic Value of C-Reactive Protein in Patients With Surgically Resectable Non-Small-Cell Lung Cancer.回顾性研究探讨 C 反应蛋白对可手术切除的非小细胞肺癌患者的预后价值。
Clin Lung Cancer. 2023 Jun;24(4):329-338. doi: 10.1016/j.cllc.2023.01.014. Epub 2023 Feb 8.
4
Ratio of C-reactive protein to albumin is a prognostic factor for operable non-small-cell lung cancer in elderly patients.C反应蛋白与白蛋白的比值是老年可手术非小细胞肺癌患者的一个预后因素。
Surg Today. 2017 Jul;47(7):836-843. doi: 10.1007/s00595-016-1448-8. Epub 2016 Nov 16.
5
A commentary on "Gustave Roussy immune score based on a three-category risk assessment scale serves as a novel and effective prognostic indicator for surgically resectable early-stage non-small-cell lung cancer: A propensity score matching retrospective cohort study".对“基于三类风险评估量表的古斯塔夫·鲁西免疫评分作为手术可切除早期非小细胞肺癌的新型有效预后指标：一项倾向评分匹配回顾性队列研究”的评论
Int J Surg. 2021 May;89:105947. doi: 10.1016/j.ijsu.2021.105947. Epub 2021 Apr 20.
6
Gustave Roussy Immune Score based on a three-category risk assessment scale serves as a novel and effective prognostic indicator for surgically resectable early-stage non-small-cell lung cancer: A propensity score matching retrospective cohort study.基于三分类风险评估量表的 Gustave Roussy 免疫评分可作为手术可切除的早期非小细胞肺癌的新型有效预后指标：一项倾向评分匹配回顾性队列研究。
Int J Surg. 2020 Dec;84:25-40. doi: 10.1016/j.ijsu.2020.10.015. Epub 2020 Oct 18.
7
A commentary on "Gustave Roussy Immune Score based on a three-category risk assessment scale serves as a novel and effective prognostic indicator for surgically resectable early-stage non-small-cell lung cancer: A propensity score matching retrospective cohort study" (Int J Surg 2020; 84: 25-40).对《基于三类风险评估量表的古斯塔夫·鲁西免疫评分作为可手术切除的早期非小细胞肺癌的新型有效预后指标：一项倾向评分匹配回顾性队列研究》的述评（《国际外科学杂志》2020年；84卷：25 - 40页）
Int J Surg. 2021 Jul;91:105990. doi: 10.1016/j.ijsu.2021.105990. Epub 2021 Jun 8.
8
Prognostic impact of thrombocytosis in resectable non-small cell lung cancer.血小板增多症对可切除非小细胞肺癌的预后影响
Interact Cardiovasc Thorac Surg. 2008 Aug;7(4):613-5. doi: 10.1510/icvts.2007.174391. Epub 2008 May 23.
9
Response to Letter to the Editor Titled "Surgery or Stereotactic Body Radiotherapy for Early Stage Lung Cancer: What is the Current Evidence?".
Clin Lung Cancer. 2020 Jan;21(1):e35-e36. doi: 10.1016/j.cllc.2019.06.016. Epub 2019 Jun 19.
10
Identification of the Best Prognostic Marker Among Immunonutritional Parameters Using Serum C-Reactive Protein and Albumin in Non-Small Cell Lung Cancer.使用血清 C 反应蛋白和白蛋白鉴定非小细胞肺癌免疫营养参数中的最佳预后标志物。
Ann Surg Oncol. 2021 Jun;28(6):3046-3054. doi: 10.1245/s10434-020-09230-x. Epub 2020 Oct 21.